From: Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer
Consumables
Price without VAT
Price incl. 20% VAT
PSMA
EUR 401.46
EUR 481.75